A*STAR and SingHealth to collaborate on big data for precision medicine and smart technologies for tackling diabetes
The MOU will bring together A*STAR’s bioinformatics and computational capabilities, and SingHealth’s clinical expertise, to integrate data from various databanks into a central database for analysis and subsequent precision medicine application.
A*STAR (Agency for Science, Technology and Research) and SingHealth signed a Memorandum of Understanding (MoU) today to find solutions for local and global healthcare challenges, and create value for Singapore’s economy. A*STAR is Singapore's lead public sector agency that spearheads economic oriented research, while SingHealth is the largest healthcare group in Singapore with 2 tertiary hospitals, 5 national specialty centres, a network of polyclinics and a community hospital.
The scientific and technical capabilities of A*STAR’s eighteen research institutes will complement SingHealth’s extensive healthcare expertise and resources, to enable seamless transition of cutting-edge healthcare discoveries and applications from bench to bedside.
The collaboration will leverage a combined talent of over 4,500 A*STAR researchers, engineers, technical support staff, as well as about 20,000 doctors, nurses and allied health professionals at SingHealth. This also includes a pool of around 400 clinician-scientists and clinician-investigators adept at both science and medicine. They will help bridge the gap between upstream research discovery and downstream clinical application.
The MOU that will be signed today builds on a history of successful collaborations, such as identifying new drug targets for advanced kidney cancer and the Asi Continue reading